Wolfram J. Jabs

Association between clinical disease activity and Epstein–Barr virus reactivation in MS

K.-P. Wandinger, Wolfram J. Jabs, Aja Siekhaus et al. · Neurology · 2000 · 299 citations

Veterinary Medicine, Immunology, Infectious Diseases +15

Development and validation of a renal risk score in ANCA-associated glomerulonephritis

Silke R. Brix, Mercedes Noriega, Pierre Tennstedt et al. · Kidney International · 2018 · 293 citations

Medicine, Internal Medicine, Nephrology +11

PATIENTS AT RISK FOR DEVELOPMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER: PLASMA VERSUS PERIPHERAL BLOOD MONONUCLEAR CELLS AS MATERIAL FOR QUANTIFICATION OF EPSTEIN-BARR VIRAL LOAD BY USING REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION1,2

Hans-Joachim Wagner, Meike Wessel, Wolfram J. Jabs et al. · Transplantation · 2001 · 217 citations

Life Sciences, Immunology, Pathology +15

The kidney as a second site of human C‐reactive protein formation <i>in vivo</i>

Wolfram J. Jabs, Birgit A. Lögering, Peter Gerke et al. · European Journal of Immunology · 2002 · 189 citations · Full text

Medicine, Immunology, Pathology +15

Local Generation of C-Reactive Protein in Diseased Coronary Artery Venous Bypass Grafts and Normal Vascular Tissue

Wolfram J. Jabs, Elisabeth Theissing, Martin Nitschke et al. · Circulation · 2003 · 156 citations

Medicine, Cardiology, Surgery +17